DS-2248

· Daiichi Sankyo

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DS-2248, covering 2020-07-10 to 2020-07-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DS-2248 in Participants With Advanced Solid Tumors [Phase 1]